Zoonotic & Vector-Borne Diseases

Authorized for children in malaria-endemic regions, this vaccine aims to bridge the gap between demand and supply, offering hope against malaria's toll.

During Lyme Disease Awareness Month, advocating for collective action in research, education, and prevention can help tackle the challenges of Lyme disease and promote healthier communities nationwide.

Importance of thorough travel history assessment, consistent surveillance, and outreach efforts to manage malaria morbidity among travelers in the US.

Study reveals concerning trends from the mosquito-borne disease impacting Canada and the US.

In a collaboration between the University of Oxford, the Ministry of Health in Rwanda, and the Rwanda Biomedical Centre, groundbreaking data on the R21/Matrix-M malaria vaccine, marks a significant shift in the malaria paradigm.

Photini Sinnis MD, professor at the Johns Hopkins School of Public Health and Deputy Director of the Johns Hopkins Malaria Research Institute, offers her expert insights into this zoonotic disease.

Both the United Nations and World Health Organization (WHO) discussed the threat of H5N1, and its potential transmission to other mammals and humans.

The New York City Department of Health and Mental Hygiene reports a record amount of Leptospirosis cases, the zoonotic disease, from rat urine.

The case involves a man who had contact with wild monkeys.

Rising dengue incidence in Puerto Rico signals broadening health concerns.

Phase 2 study of healthcare workers' safety in high-risk populations.

The assay, the cobas Malaria test, is manufactured by Roche, and will be available in the United States at the end of Q2 2024.

The increase highlights the threat posed by climate change and the need for innovative preparedness, prevention, and mitigation tools.

How acute malnutrition undermines Malaria in children under 5 years old.

State health officials did not disclose the origin of transmission.

Climate change's role in the expanding threat of vector-borne diseases.

CDC addresses rising vector-borne diseases with an initiative to enhance public health protection.

Over 1 billion people are estimated to be affected by 20 conditions of neglected tropical diseases (NTDs), though they are often unheard of by many. Heather Saunders, MPH, RN, CIC, delves into 5 of these diseases and discusses efforts to stop their spread.

Trial demonstrates promising results for oral treatment towards the disease's vector.

Innovative treatments, challenging prevention, and impact of climate change.

The impact of the new surveillance criteria on case identification.

A senior microbiologist gives audiences of sister brands, Infection Control Today and Contagion, an insight into leishmaniasis, a potentially fatal disease.

Oregon resident catches plague through a cat-to-human transmission.

First victim of the Alaskapox Virus highlights the need for increased research.

Study offers new insight into the relationship between Zika Virus and Dengue Virus in tropical regions.

Phase 3 trial is highly effective in preventing symptomatic disease.

CDC's preventive strategies against the world's most prevalent mosquito-borne disease.

Study examines the complexity between human health and tick-borne diseases.

A new human trial aims to prevent the fatal, zoonotic-borne disease.

Valneva’s VLA1553 (Ixchiq) vaccine was shown to met its preliminary endpoint, with 98.9% of participants reaching protective levels of chikungunya virus neutralizing antibodies 1 month after vaccination.